As a result, consistent with their expression changes in tumor samples compared with adjacent samples, ENPP2 and ETS1 showed decreased expression levels in MDA-MB-231, a highly aggressive cell line, compared with MCF-7, a weakly aggressive cell line. Here, ENPP2 is linked to neoplasm.